HotSheets 2010  

January - March | April - June | July - September | October - Decembar

2010 Us TOO HotSheet Article Index


January   | View Newsletter

February | View Newsletter

March | View Newsletter


  • Degarelix vs. Leuprolide in Advanced Prostate Cancer: Further Analysis of a Phase III Pivotal Trial

  • Us TOO Names New Board Reps for 2010

  • Dendreon Receives FDA Acknowledgement of Complete Response for Provenge BLA Resubmission

  • Doc Moyad’s “No Bogus Science” Column—Statins & Low Cholesterol “Hit Another Home Run”

  • Drug Eases ADT Side Effect in Men

  • PSA Screening Should Be Offered to Older Men

  • Read more..


  • ERSPC Study Shows PSA Screening Reduced Prostate Cancer Deaths by 20 Percent

  • PSA Velocity May Help Identify Insignificant Prostate Cancer

  • NCCN Prostate Cancer Guidelines Stress Careful Consideration of Active Surveillance

  • An Update of the Gleason Grading System

  • Coffee May Cut Risk of Prostate Cancer

  • Radiofrequency Ablation Safe and Effective for Reducing Pain from Bone Metastases

  • Ask Dr. Snuffy Myers

  • Read more..


  • Public-Private Divide in Prostate Cancer Treatment

  • Exercise May Prevent Incontinence from Prostate Cancer Surgery

  • Similar Effectiveness among Management Options for Low-Risk Prostate Cancer

  • Soy May Protect Against Prostate Cancer

  • ZERO’s ―Prostate Polar Plunge

  • Ask Dr. Snuffy Myers

  • Alternative Prostate Cancer Vaccine Shows Promise

  • Frequent Sex and Masturbation in 20s and 30s Linked to Higher Prostate Cancer Risk

  • Read more..


April | View Newsletter

MAY | View Newsletter

June | View Newsletter


  • New Prostate Cancer Screening Guidelines – Commentary by Dr. Len Lichtenfeld

  • AUA Responds to Updated ACS Guidelines

  • Complex New Guidelines from Multiple Organizations Confuse Men about Prostate Cancer Screening

  • American Cancer Society – Ignorance is Bliss When it Comes to Prostate Cancer

  • Which Men Should Take Finasteride?

  • Robot-Assisted Surgery Is no Better Treatment for Prostate Cancer

  • American Cancer Society Updates Guidelines

  • Doc Moyad’s “No Bogus Science” Column – Weight Loss Supplements Are a Problem So Be Careful

  • Read more..


  • ASCO Statement on the Passage of the Patient Protection & Affordable Health Care Act

  • A Treatment for Prostate Cancer “Inadequate” Half the Time

  • Positive Results for Sanofi-Aventis Drug

  • PSA & the PSA Test: What the Public Needs to Know

  • Infertility & Prostate Cancer May Have a Common Cause

  • Ask Dr. Snuffy Myers

  • Doc Moyad’s “No Bogus Science” Column – L-Theanine Anti-Stress Amino Acid Found in Tea

  • Doctor Chodak’s Bottom Line

  • Read more..


  • FDA Approves Prostate Cancer Vaccine

  • Active Surveillance May Not Be Best Option

  • MDV3100 Shows “Substantial Activity” in Advanced Prostate Cancer

  • Radiation for Prostate Cancer Lacks Data

  • Discussing Provenge with Cancer Patients®

  • Prostate Cancer Progresses More Quickly in African-American Men

  • Ask Dr. Snuffy Myers

  • Doc Moyad’s “No Bogus Science” Column – Provenge® Receives FDA Approval

  • FDA Scrutiny of GnRH Agonists Continues

  • Degarelix Shows Promise as Second-Line Hormonal Therapy for Prostate Cancer Patients

  • Read more..


July | View Newsletter

August | View Newsletter

September | View Newsletter


  • RT Shown Beneficial for Prostate Cancer Subset

  • Denosumab Extends Time to Bone Events

  • Us TOO Seeks Board Member Applications

  • High-Intensity Focused Ultrasound (HIFU) Non-Inferior to EBRT for Prostate Cancer

  • Cabazitaxel Benefit Confirmed in Prostate Cancer Now FDA Approved (Jevtana®, sanofi-aventis)

  • Doc Moyad’s “No Bogus Science” Column – “Exercise Ups Cialis®, Levitra® & Viagra®

  • Pelvic RT Increases Hip Fracture Risk in Men

  • Bevacizumab (Avastin®) Fails to Prolong Survival in Resistant Prostate Cancer

  • PSA Misses the Mark in Active Surveillance

  • Read more..


  • Medicare to Review Provenge® Coverage

  • Patients Face Yearlong Rationing of Provenge

  • Leather Wristbands Help Raise Awareness, Prostate Cancer Funds

  • PSA Test Does Cut Prostate Cancer Deaths

  • Cabazitaxel (Jevtana®) New Chemotherapy Approved for Advanced Prostate Cancer

  • Doc Moyad’s “No Bogus Science” Column – “Too Much Vitamin D3 Is Not a Good Thing”

  • Ask Doctor Snuffy Myers

  • Seeking Patients for New Study to Improve Prediction of Prostate Biopsy Results

  • Statins Reduce PSA Spikes After Surgery

  • Read more..


  • Immunotherapy Benefits Prostate Cancer

  • Bone Density May Predict Prostate Cancer

  • Dendreon’s $93K Price Must Be Paid by US

  • PSA Screening Can Lead to Overtreatment

  • PAF Announces Additional Support for Co-Pay Relief Program for Prostate Cancer

  • Doc Moyad’s “No Bogus Science” Column – “Too Much Folic Acid May Not Be Good”

  • Clinically Localized Prostate Cancer Treated With Permanent Interstitial Brachytherapy

  • Ask Doctor Snuffy Myers

  • Stand Up to Cancer Is Back

  • Five New Genetic Variations Linked to Prostate Cancer in Study on Japanese Men

  • Read more..


October  | View Newsletter

November | View Newsletter

December | View Newsletter


  • Oct 13 Webinar: Understanding Diagnostic Testing for Prostate Cancer Patients

  • Comorbidities May Be Key in Prostate Cancer Treatment Decisions

  • What Are Men Being Told About Their Treatment Options for Prostate Cancer

  • My Prostate Cancer Roadmap – Resource for Men with Advanced Prostate Cancer

  • Summary of Us TOO’s Summit, Symposium and 20th Anniversary Celebration

  • Abiraterone Acetate Study Unblinded after Meeting Pre-Determined Criteria

  • Ask Doctor Snuffy Myers

  • Doctor Chodak’s Bottom Line

  • Doc Moyad’s “No Bogus Science” Column – “Let’s Walk the Talk This Month!”

  • Prostate Biopsy Can Cause Urinary and Erectile Problems

  • Read more..


  • Us TOO Board Welcomes 2 New Members

  • Risk Factors for Prostate Cancer Differ Between Native and Foreign Born Black Men

  • Cabazitaxel – New Approach for Prostate Cancer

  • Protein Array Accurate for Prostate CA

  • AstraZeneca Drug Fails vs. Prostate Cancer

  • No Prostate Cancer Indication for Sunitinib

  • Us TOO Seeking Nominations for Kaps Award

  • Teva Launches Prostate Cancer Phase III Study

  • Comparing Radiation Treatments

  • POM Wonderful vs. Federal Trade Commission

  • Us TOO Seeks Board Member Applications

  • Read more..


  • Holiday Giving? Remember Us TOO

  • Drug Extends Survival in Prostate Cancer

  • Cost Should Enter Effectiveness Equation

  • Atypical Prostate Biopsy Should Be Repeated

  • Calypso Dynamic Edge Gating Technology Receives FDA 510(k) Clearance

  • PSA Test Reduces Risk of Spread if Prostate Cancer Strikes

  • VA Begins Paying Benefits for New Agent Orange Exposure

  • New Warnings on Prostate Cancer Drugs

  • Aspirin Associated with Reduced Risk of Prostate Cancer Death

  • Doc Moyad’s “No Bogus Science” Column – “Mega-Dose Vitamins”

  • Ask Doctor Snuffy Myers

  • Doctor Chodak’s Bottom Line

  • Read more..


Facebook -  Twitter -  LinkedIn - Inspire prostate cancer discussions – 

Contact Us | Privacy Policy | Terms & Conditions | Disclaimer   

Copyright © 2005-2017 Us TOO International, Inc.
Designed and hosted by ACCESS Medical Group, Ltd.